Cell entry by SARS-CoV-2

R Peng, LA Wu, Q Wang, J Qi, GF Gao - Trends in biochemical sciences, 2021 - cell.com
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) invades host cells by interacting
with receptors/coreceptors, as well as with other cofactors, via its spike (S) protein that further …

Enabling the'host jump': structural determinants of receptor-binding specificity in influenza A viruses

Y Shi, Y Wu, W Zhang, J Qi, GF Gao - Nature Reviews Microbiology, 2014 - nature.com
The recent emergence of the H7N9 avian influenza A virus and its ability to infect humans
emphasize the epidemic and pandemic potential of these viruses. Interspecies transmission is …

[PDF][PDF] Structural and functional basis of SARS-CoV-2 entry by using human ACE2

…, C Qiao, Y Hu, KY Yuen, Q Wang, H Zhou, J Yan, J Qi - Cell, 2020 - cell.com
The recent emergence of a novel coronavirus (SARS-CoV-2) in China has caused significant
public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2…

[PDF][PDF] Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2

…, D Li, R Zhang, M Tian, L Fu, Y Gao, X Zhao, K Liu, J Qi… - Cell, 2022 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic continues worldwide with many
variants arising, some of which are variants of concern (VOCs). A recent VOC, omicron (B.1.1.529)…

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

…, W Huang, WJ Liu, G Wu, B Zhang, L Wang, J Qi… - Nature, 2020 - nature.com
An outbreak of coronavirus disease 2019 (COVID-19) 1 , 2 – 3 , caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) 4 , has spread globally. Countermeasures …

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

…, W Tan, X Lu, C Fan, Q Wang, Y Liu, C Zhang, J Qi… - Science, 2020 - science.org
Neutralizing antibodies could potentially be used as antivirals against the coronavirus disease
2019 (COVID-19) pandemic. Here, we report isolation of four human-origin monoclonal …

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Y Yuan, D Cao, Y Zhang, J Ma, J Qi, Q Wang… - Nature …, 2017 - nature.com
The envelope spike (S) proteins of MERS-CoV and SARS-CoV determine the virus host
tropism and entry into host cells, and constitute a promising target for the development of …

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

G Lu, Y Hu, Q Wang, J Qi, F Gao, Y Li, Y Zhang… - Nature, 2013 - nature.com
The newly emergent Middle East respiratory syndrome coronavirus (MERS-CoV) can cause
severe pulmonary disease in humans 1 , 2 , representing the second example of a highly …

[HTML][HTML] Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

…, P Niu, H Song, Y Shi, X Li, W Tan, J Qi… - Nature …, 2020 - nature.com
COVID-19 was declared a pandemic on March 11 by WHO, due to its great threat to global
public health. The coronavirus main protease (M pro, also called 3CLpro) is essential for …

[PDF][PDF] A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS

…, Y Li, H Cheng, Y Yuan, W Zhang, C Ke, G Wong, J Qi… - Cell, 2020 - cell.com
Vaccines are urgently needed to control the ongoing pandemic COVID-19 and previously
emerging MERS/SARS caused by coronavirus (CoV) infections. The CoV spike receptor-…